Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections
NCT ID: NCT00990392
Last Updated: 2015-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2009-11-30
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus
NCT00175370
Antiseptic Use and Dressing Application
NCT00389558
Study of Catheter-related Infections Using Antibiotic-coated Versus Conventional Catheters in Children
NCT00370149
Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
NCT06019897
Topical Antibiotic Irrigation (Gentamicin) in Prophylaxis of Midfacial Fracture Surgical Wounds
NCT03483363
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Polysporin Triple Therapy
Polysporin Triple Therapy ointment applied to the insertion point at the time of CVC placement and twice within the first week.
Polysporin Triple Therapy ointment
Polysporin Triple Therapy ointment applied to the insertion point at the time of CVC placement and twice within the first week.
Placebo
Petroleum jelly
Petroleum Jelly
Petroleum jelly applied to the insertion point at the time of CVC placement and twice within the first week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polysporin Triple Therapy ointment
Polysporin Triple Therapy ointment applied to the insertion point at the time of CVC placement and twice within the first week.
Petroleum Jelly
Petroleum jelly applied to the insertion point at the time of CVC placement and twice within the first week.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* CVC for hemodialysis
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fraser Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steve Reynolds
Critical care Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven Reynolds, MD
Role: PRINCIPAL_INVESTIGATOR
Fraser Health Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Columbian Hospital
New Westminster, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol. 2003 Jan;14(1):169-79. doi: 10.1097/01.asn.0000038688.76195.a4.
James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR; Alberta Kidney Disease Network. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med. 2008 Apr 15;148(8):596-605. doi: 10.7326/0003-4819-148-8-200804150-00004.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Kerrie-333333
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.